GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions.

Page R, Martinez O, Larcombe-Young D, Bugallo-Blanco E, Papa S, Perucha E

Open source

DOI
10.1093/immadv/ltaf018
Published
2025
Container
Immunotherapy advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/immadv/ltaf018,
  title = {GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions.},
  author = {Page R and Martinez O and Larcombe-Young D and Bugallo-Blanco E and Papa S and Perucha E},
  year = {2025},
  journal = {Immunotherapy advances},
  doi = {10.1093/immadv/ltaf018},
  url = {https://doi.org/10.1093/immadv/ltaf018}
}

RIS

TY  - JOUR
TI  - GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions.
AU  - Page R
AU  - Martinez O
AU  - Larcombe-Young D
AU  - Bugallo-Blanco E
AU  - Papa S
AU  - Perucha E
PY  - 2025
JO  - Immunotherapy advances
DO  - 10.1093/immadv/ltaf018
UR  - https://doi.org/10.1093/immadv/ltaf018
ER  - 

APA

R, P., O, M., D, L., E, B., S, P., & E, P. (2025). GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions.. Immunotherapy advances. https://doi.org/10.1093/immadv/ltaf018

Source records